Effects of BCG on lysozyme and “active” T cells in patients with malignant melanoma: A preliminary study

Clinical Immunology and Immunopathology - Tập 12 - Trang 191-203 - 1979
Ronald Lieberman1,2,3, H.Hugh Fudenberg1,2,3
1Department of Medicine, University of California School of Medicine, San Francisco, California 94122 USA
2Cancer Research Institute, University of California School of Medicine, San Francisco, California 94122 USA
3Department of Basic and Clinical Immunology and Microbiology, Medical University of South Carolina, Charleston, South Carolina 29403 USA

Tài liệu tham khảo

Freund, 1956, Advan. Tuberc. Res., 7, 130 Old, 1961, Cancer Res., 21, 1281 Zbar, 1971, Science, 172, 271, 10.1126/science.172.3980.271 Mackaness, 1973, J. Nat. Cancer Inst., 51, 1655, 10.1093/jnci/51.5.1655 Bast, 1974, N. Engl. J. Med., 290, 1413, 10.1056/NEJM197406202902506 Bast, 1974, N. Engl. J. Med., 290, 1458, 10.1056/NEJM197406272902605 Mackaness, 1974, J. Exp. Med., 139, 1540, 10.1084/jem.139.6.1540 Lieberman, 1974, Int. J. Cancer, 14, 401, 10.1002/ijc.2910140315 Cohn, 1963, J. Exp. Med., 118, 991, 10.1084/jem.118.6.991 Myrvik, 1962, J. Immunol., 89, 745, 10.4049/jimmunol.89.5.745 Clark, 1969, Cancer Res., 29, 705 Sparks, 1973, N. Engl. J. Med., 289, 827, 10.1056/NEJM197310182891603 Wybran, 1971, Trans. Ass. Amer. Physicians, 84, 239 Osserman, 1966, J. Exp. Med., 124, 921, 10.1084/jem.124.5.921 Morton, 1974, Ann. Surg., 180, 635, 10.1097/00000658-197410000-00029 Gutterman, 1973, Lancet, 1, 1208, 10.1016/S0140-6736(73)90526-6 Nathanson, 1974, Semin. Oncol., 1, 337 Bluming, 1972, Ann. Intern. Med., 76, 405, 10.7326/0003-4819-76-3-405 Morton, 1970, Ann. Surg., 172, 740, 10.1097/00000658-197010000-00018 Lieberman, 1975, Cancer, 35, 756, 10.1002/1097-0142(197503)35:3<756::AID-CNCR2820350331>3.0.CO;2-Z Fudenberg, 1975, N. Engl. J. Med., 292, 475, 10.1056/NEJM197502272920910 Horowitz, 1975, Clin. Immunol. Immunopathol., 4, 405, 10.1016/0090-1229(75)90009-4 Fontan, 1976, Lancet, 2, 1247, 10.1016/S0140-6736(76)91176-4 Eilber, 1970, Cancer, 25, 362, 10.1002/1097-0142(197002)25:2<362::AID-CNCR2820250213>3.0.CO;2-V Gordon, 1974, J. Exp. Med., 139, 1228, 10.1084/jem.139.5.1228 Pascual, 1973, N. Engl. J. Med., 289, 1074, 10.1056/NEJM197311152892007 Perillie, 1973, Amer. J. Med. Sci., 265, 297, 10.1097/00000441-197304000-00005 Falchuk, 1975, N. Engl. J. Med., 292, 395, 10.1056/NEJM197502202920805 Shevach, 1973, Transplant. Rev., 16, 3 Wybran, 1974, Int. J. Cancer, 13, 515, 10.1002/ijc.2910130411 Perlmann, 1969, Advan. Immunol., 11, 117, 10.1016/S0065-2776(08)60479-4 Wolfe, 1977, J. Immunol., 119, 1152, 10.4049/jimmunol.119.3.1152 Herberman, 1977, Int. J. Cancer, 19, 555, 10.1002/ijc.2910190417 Hibbs, 1972, Nature New Biol, 235, 48, 10.1038/newbio235048a0